Komori
Resol Holdings (5261) · FactRestated

Recognition of Losses Related to COVID-19

First written in FY2021-Q1. 2 of 11 entries say "Restated". Latest entry: FY2024-Q2.

11entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2021-Q1 – FY2024-Q22020: 220202021: 420212022: 420222023: 12023
Same theme, other companies
Fixed-cost losses from facility closures due to COVID-19A theme 45 companies write about · 45 as a headwind · 0 as a tailwind

3 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 45 companies compared. The sentences above are computed from all 45.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q2RestatedAnnual report

    「During the consolidated accounting period for the second quarter, there were no material changes to the assumptions concerning the impact of the spread of COVID-19 described under “Significant Accounting Estimates” in the securities report for the previous consolidated fiscal year.」

    The company stated that there were no material changes to the assumptions underlying its accounting estimates concerning the impact of the spread of COVID-19.
  2. FY2023-Q2RestatedAnnual report

    「Current second-quarter cumulative consolidated period (from 1 April 2022 to 30 September 2022) There are no applicable matters.」

    No losses attributable to COVID-19 were recorded in the cumulative period for the second quarter, either, compared with losses recorded in the same period of the previous year.
  3. FY2023-Q1No quarterly COVID-19 losses recordedAnnual report

    「Cumulative consolidated period for the first quarter (1 April 2022 to 30 June 2022) There were no applicable matters.」

    No losses attributable to COVID-19 were recorded in the cumulative period for the first quarter, compared with ¥126.617 million recorded in the same period of the previous year.
  4. FY2022Full-year decrease in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 221,973」

    Full-year losses from fixed costs and other costs incurred during temporary closures due to the pandemic amounted to ¥221.973 million, down from ¥531.359 million in the previous fiscal year.
  5. FY2022-Q3Slight cumulative increase in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 517,573 214,269」

    The company recorded ¥214.269 million in losses attributable to COVID-19, including fixed costs incurred during the temporary closure of business facilities and other costs, down from ¥517.573 million in the same period of the previous year. This was a slight increase from ¥214.068 million in the cumulative period through the previous quarter.
  6. FY2022-Q2Cumulative decrease in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 214,068」

    The company recorded ¥214.068 million in losses attributable to COVID-19, including fixed costs incurred during the temporary closure period, down from ¥504.197 million in the same period of the previous year.
  7. FY2022-Q1Quarterly decrease in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 126,617」

    The company recorded ¥126.617 million in losses attributable to COVID-19, including fixed costs incurred during the temporary closure period. This was down from ¥327.240 million in the same period of the previous year.
  8. FY2021Full-year increase in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 531,359」

    The company recorded ¥531.359 million in full-year losses attributable to COVID-19, including fixed costs incurred during the temporary closure of business facilities and other costs.
  9. FY2021-Q3Increase in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 - 517,573」

    The company recorded ¥517.573 million in losses attributable to COVID-19, including fixed costs incurred during the temporary closure of business facilities and other costs. Losses attributable to the pandemic continued to be recorded, whereas there had been none in the same period of the previous year.
  10. FY2021-Q2Increase in losses attributable to COVID-19Annual report

    「Losses attributable to COVID-19 - 504,197」

    The company recorded ¥504.197 million in losses attributable to COVID-19 as an extraordinary loss, including fixed costs incurred during the temporary closure period.
  11. FY2021-Q1First statedAnnual report

    「Losses attributable to COVID-19 - 327,240」

    The company recorded ¥327.240 million in losses attributable to COVID-19 as an extraordinary loss, including fixed costs incurred during the temporary closure of business facilities under the state of emergency and other measures.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Resol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.